The heart simulator is the world’s best technology developed by the University of Tokyo and Fujitsu Limited over more than 10 years with a supercomputer.
The movement of an individual heart is reproduced accurately from micro to macro level through input of imaging data such as CT and ultrasound together with clinical data.
We are developing a new programmed medical device utilizing this simulation technology.
Visit “Heart Simulator” to learn more
To bring this device to the world, it is necessary to ensure quality and safety. This requires pharmaceutical approval in Japan, FDA 510(k) in the U.S., and CE mark in Europe.
The application know-how of the company authorized for manufacturing and distribution of medical device who is responsible for quality and safety is essential.
Therefore, PIA Co., Ltd., which has a business license for “Class 1 medical device manufacturing and sales business” which handles advanced medical equipment, has been added as a business partner. As a proof of this, on April 23, 2020, we signed a joint research agreement with UT-Heart Research Institute Co., Ltd. (a venture from the University of Tokyo), Fujitsu, and PIA.
Visit Movie to learn the contract details
Japan Medical Device Corporation was founded on 16th November, 2020 independently by PIA. JMD will take over PIA’s manufacturing and distribution know-how for the business of the heart simulator developed by the University of Tokyo and Fujitsu to target the world. One of our goals is to be listed on NASDAQ in the future.